Navigating Chronic Pain in Patients with Cirrhosis: Unique Analgesic Considerations and Non-Pharmacologic Options
Abstract
Purpose of review: Chronic pain affects 40-80% of patients with chronic liver disease, yet management remains challenging due to impaired drug metabolism, limited evidence, and the absence of disease-specific guidelines. This review summarizes the evidence for pharmacologic and non-pharmacologic pain management strategies in patients with cirrhosis.
Recent findings: Nearly every analgesic class carries risk in patients with cirrhosis, and most prescribing recommendations are based on pharmacokinetic data and expert opinion rather than clinical trials. Opioid prescribing has declined in recent years, but nonopioid alternatives have not increased proportionally. Non-pharmacologic modalities have been scarcely studied in this population. Shared comorbidities and risk factors, including alcohol use, metabolic disease, sleep disturbances, and psychiatric conditions, represent modifiable therapeutic targets that may improve pain while altering liver disease trajectory.
Summary: Pain management in patients with cirrhosis requires an individualized, multimodal approach integrating pharmacologic therapy, non-pharmacologic interventions, and comorbidity management. Further research, including both well-designed observational studies and prospective trials, is needed to generate evidence-based guidance for this underserved population.
Read the paper
Related studies
- Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial
- Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease
- Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience
- Celecoxib or naproxen treatment does not benefit depressive symptoms in persons aged 70 and over: findings from a randomized controlled trial
- Comparative Clinical Effectiveness of Nonsurgical Treatment Methods in Patients With Lumbar Spinal Stenosis: A Randomized Clinical Trial
- Efficacy and safety of adalimumab by intra-articular injection for moderate to severe knee osteoarthritis: An open-label randomized controlled trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.